Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention

Journal of Clinical Virology

Volumn 34, Issue SUPPL. 1, 2005, Pages

  Lavanchy, D ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Burden; Epidemiology; Hepatitis B; Prevention; Vaccine

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B VACCINE;

ARTICLE; CHRONIC HEPATITIS; DELTA AGENT HEPATITIS; DISEASE SEVERITY; HEALTH CARE COST; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; NONHUMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

CARCINOMA, HEPATOCELLULAR; HEPATITIS B; HEPATITIS B VACCINES; HUMANS;

EID: 32044449655     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(05)00384-7     Document Type: Article

References (21)

1. Brooks E.A., Lacey L.F., Payne S.L., and Miller D.W. Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States Am J Manag Care 7 7 2001 677 682
2. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., and Kong M.S. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group N Engl J Med 336 26 1997 1855 1859
3. el-Saved H.E., Abaza S.M., Mehanna S., and Winch P.J. The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt Acta Trop 68 2 1997 229 237
4. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 10 1999 745 750
5. Giacchino R., Zancan L., Vajro P., Verucchi G., Resti M., and Barbera C. Hepatitis B virus infection in native versus immigrant or adopted children in Italy following the compulsory vaccination Infection 29 4 2001 188 191
6. Kane A., Lloyd J., Zaffran M., Simonsen L., and Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates Bull World Health Organ 77 10 1999 801 817
7. Lee W.M. Hepatitis B virus infection N Engl J Med 337 24 1997 1733 1745
8. Lemon S.M., Layden T.J., Seeff L., Suzuki H., Nishioka K., and Mishiro S. The 20th United States-Japan Joint Hepatitis Panel Meeting Hepatology 31 3 2000 800 806
9. (Suppl) Margolis H.S., Schatz G.C., and Kane M.A. Development of recommendations for control of hepatitis B virus infections: the role of cost analysis discussion S93-S94 Vaccine 8 1990 S69 S73
10. Ni Y.H., Chang M.H., Huang L.M., Chen H.L., Hsu H.Y., and Chiu T.Y. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination Ann Intern Med 135 9 2001 796 800
11. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 2 2001 153 156
12. Pokorski R.J., and Ohlmer U. Long-term morbidity and mortality in Chinese insurance applicants infected with the hepatitis B virus J Insur Med 33 2 2001 143 164
13. Rosenberg D., Cook S., Eaton S., Saunders W., and Lanza L. The epidemiology, treatment patterns and resource utilization of hepatitis B patients in a large insured New England population Pharmcoepidmiol Drug Saf 7 suppl 2 1998 S132
14. Stroffolini T., Mele A., Tosti M.E., Gallo G., Balocchini E., and Ragni P. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy J Hepatol 33 6 2000 980 985
15. VHPB Prevention and control of viral hepatitis in migrants and refugees. VHPB-meeting Viral Hepatitis 8 2 2000 1 7
16. WHO Hepatitis B Vaccine-making global progress Update, Expanded Programme on Immunization 1996 WHO
17. WHO The World Health Report 1997 WHO
18. (Revised October 2000) WHO Hepatitis B Fact Sheet No. 204 Web site 2000 WHO
19. Wong J.B., Koff R.S., Tine F., and Pauker S.G. Cost-effectiveness of interferonalpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B Ann Intern Med 122 9 1995 664 675
20. Yang B.M., Paik S.W., Hahn O.S., Yi D.H., Choi M.S., and Payne S. Economic evaluation of the societal costs of hepatitis B in South Korea J Gastroenterol Hepatol 16 3 2001 301 318
21. Yu M.C., Yuan J.M., Govindarajan S., and Ross R.K. Epidemiology of hepatocellular carcinoma Can J Gastroenterol 14 8 2000 703 709